Anti-fouling and/or anti-thrombotic medical devices
The present disclosure relates to anti-fouling and/or anti-thrombotic medical devices, methods for reducing fouling and/or thrombosis associated with medical devices, and methods for coating substrates to reduce fouling and/or thrombosis. Certain embodiments of the present disclosure provide an anti-fouling and/or anti-thrombotic medical device comprising a metallic substrate comprising a hyperbranched polyglycerol coating.
1. A method of reducing fouling and/or thrombosis associated with a medical device comprising a metallic substrate, the method comprising activating the metallic substrate by plasma treatment and coating the metallic substrate with a hyperbranched polyglycerol by exposing the activated metallic substrate to pure glycidol or a solution comprising at least 90% glycidol.
2. The method according to claim 1 , wherein the coating of the metallic substrate comprises polymerisation of glycidol monomers on the metallic substrate.
3. The method according to claim 1 , wherein the coating comprises activation of the metallic substrate by plasma treatment in the presence of an inert and/or non-depositing gas.
4. The method according to claim 1 , wherein the medical device comprises a stent, a cannula, or a valve.
5. The method according to claim 4 , wherein the stent, the cannula or the valve comprises a metallic substrate comprising a steel alloy, a nickel titanium alloy or a cobalt chromium alloy.
6. A method of coating a metallic substrate with a hyperbranched polyglycerol, the method comprising polymerisation of glycidol monomers to form a hyperbranched polyglycerol on the metallic substrate activated by plasma treatment and exposing the plasma activated metallic substrate to pure glycidol or a solution comprising at least 90% glycidol and thereby coating the substrate with the hyperbranched polyglycerol.